APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nimodipine Sustained Release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nimodipine Sustained Release Tablets Market Analysis and Forecast 2026-2032

Report ID 17401710021 January 2026192 pages

Choose your research edition.

Industry ResearchNimodipine Sustained Release Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Nimodipine Sustained Release Tablets Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Nimodipine Sustained Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nimodipine Sustained Release Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Nimodipine Sustained Release Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nimodipine Sustained Release Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nimodipine Sustained Release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nimodipine Sustained Release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nimodipine Sustained Release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nimodipine Sustained Release Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nimodipine Sustained Release Tablets include Arbor Pharmaceuticals, Bayer Vital, Bionpharma, Heritage Pharmaceuticals, Pharmaceutics International, Sofgen Pharmaceuticals, Wuhan HITECK Biopharmaceutical, Sihuan Pharmaceutical and Jiangsu Kanion Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nimodipine Sustained Release Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nimodipine Sustained Release Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Nimodipine Sustained Release Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nimodipine Sustained Release Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nimodipine Sustained Release Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nimodipine Sustained Release Tablets sales, projected growth trends, production technology, application and end-user industry.

Nimodipine Sustained Release Tablets Segment by Company

Arbor Pharmaceuticals

Bayer Vital

Bionpharma

Heritage Pharmaceuticals

Pharmaceutics International

Sofgen Pharmaceuticals

Wuhan HITECK Biopharmaceutical

Sihuan Pharmaceutical

Jiangsu Kanion Pharmaceutical

Qilu Pharmaceutical

Shandong Yunmen Pharmaceutical

Yabao Pharmaceutical Group

Nimodipine Sustained Release Tablets Segment by Type

30mg/Piece

60mg/Piece

Others

Nimodipine Sustained Release Tablets Segment by Application

Hospital

Pharmacy

Others

Nimodipine Sustained Release Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nimodipine Sustained Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nimodipine Sustained Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nimodipine Sustained Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nimodipine Sustained Release Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nimodipine Sustained Release Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nimodipine Sustained Release Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nimodipine Sustained Release Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 30mg/Piece Major Manufacturers Table 3. 60mg/Piece Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Nimodipine Sustained Release Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Others Major Manufacturers Table 9. Nimodipine Sustained Release Tablets Industry Trends Table 10. Nimodipine Sustained Release Tablets Industry Drivers Table 11. Nimodipine Sustained Release Tablets Industry Opportunities and Challenges Table 12. Nimodipine Sustained Release Tablets Industry Restraints Table 13. Global Nimodipine Sustained Release Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Nimodipine Sustained Release Tablets Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Nimodipine Sustained Release Tablets Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Nimodipine Sustained Release Tablets Revenue Market Share by Region (2021-2026) Table 17. Global Nimodipine Sustained Release Tablets Revenue Market Share by Region (2027-2032) Table 18. Global Nimodipine Sustained Release Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Nimodipine Sustained Release Tablets Sales by Region (2021-2026) & (K Units) Table 20. Global Nimodipine Sustained Release Tablets Sales by Region (2027-2032) & (K Units) Table 21. Global Nimodipine Sustained Release Tablets Sales Market Share by Region (2021-2026) Table 22. Global Nimodipine Sustained Release Tablets Sales Market Share by Region (2027-2032) Table 23. Global Nimodipine Sustained Release Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Nimodipine Sustained Release Tablets Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Nimodipine Sustained Release Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Nimodipine Sustained Release Tablets Sales Market Share by Manufacturers (2021-2026) Table 27. Global Nimodipine Sustained Release Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Nimodipine Sustained Release Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Nimodipine Sustained Release Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Nimodipine Sustained Release Tablets Manufacturers, Product Type & Application Table 31. Global Nimodipine Sustained Release Tablets Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Nimodipine Sustained Release Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Nimodipine Sustained Release Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nimodipine Sustained Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Nimodipine Sustained Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2021-2026) Table 38. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2027-2032) Table 39. Global Nimodipine Sustained Release Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Nimodipine Sustained Release Tablets Sales by Type (2021-2026) & (K Units) Table 41. Global Nimodipine Sustained Release Tablets Sales by Type (2027-2032) & (K Units) Table 42. Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2021-2026) Table 43. Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2027-2032) Table 44. Global Nimodipine Sustained Release Tablets Price by Type (2021-2026) & (US$/Unit) Table 45. Global Nimodipine Sustained Release Tablets Price by Type (2027-2032) & (US$/Unit) Table 46. Global Nimodipine Sustained Release Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Nimodipine Sustained Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Nimodipine Sustained Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2021-2026) Table 50. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2027-2032) Table 51. Global Nimodipine Sustained Release Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Nimodipine Sustained Release Tablets Sales by Application (2021-2026) & (K Units) Table 53. Global Nimodipine Sustained Release Tablets Sales by Application (2027-2032) & (K Units) Table 54. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2021-2026) Table 55. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2027-2032) Table 56. Global Nimodipine Sustained Release Tablets Price by Application (2021-2026) & (US$/Unit) Table 57. Global Nimodipine Sustained Release Tablets Price by Application (2027-2032) & (US$/Unit) Table 58. Arbor Pharmaceuticals Company Information Table 59. Arbor Pharmaceuticals Business Overview Table 60. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product Portfolio Table 62. Arbor Pharmaceuticals Recent Development Table 63. Bayer Vital Company Information Table 64. Bayer Vital Business Overview Table 65. Bayer Vital Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bayer Vital Nimodipine Sustained Release Tablets Product Portfolio Table 67. Bayer Vital Recent Development Table 68. Bionpharma Company Information Table 69. Bionpharma Business Overview Table 70. Bionpharma Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Bionpharma Nimodipine Sustained Release Tablets Product Portfolio Table 72. Bionpharma Recent Development Table 73. Heritage Pharmaceuticals Company Information Table 74. Heritage Pharmaceuticals Business Overview Table 75. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product Portfolio Table 77. Heritage Pharmaceuticals Recent Development Table 78. Pharmaceutics International Company Information Table 79. Pharmaceutics International Business Overview Table 80. Pharmaceutics International Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pharmaceutics International Nimodipine Sustained Release Tablets Product Portfolio Table 82. Pharmaceutics International Recent Development Table 83. Sofgen Pharmaceuticals Company Information Table 84. Sofgen Pharmaceuticals Business Overview Table 85. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product Portfolio Table 87. Sofgen Pharmaceuticals Recent Development Table 88. Wuhan HITECK Biopharmaceutical Company Information Table 89. Wuhan HITECK Biopharmaceutical Business Overview Table 90. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product Portfolio Table 92. Wuhan HITECK Biopharmaceutical Recent Development Table 93. Sihuan Pharmaceutical Company Information Table 94. Sihuan Pharmaceutical Business Overview Table 95. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio Table 97. Sihuan Pharmaceutical Recent Development Table 98. Jiangsu Kanion Pharmaceutical Company Information Table 99. Jiangsu Kanion Pharmaceutical Business Overview Table 100. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio Table 102. Jiangsu Kanion Pharmaceutical Recent Development Table 103. Qilu Pharmaceutical Company Information Table 104. Qilu Pharmaceutical Business Overview Table 105. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio Table 107. Qilu Pharmaceutical Recent Development Table 108. Shandong Yunmen Pharmaceutical Company Information Table 109. Shandong Yunmen Pharmaceutical Business Overview Table 110. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio Table 112. Shandong Yunmen Pharmaceutical Recent Development Table 113. Yabao Pharmaceutical Group Company Information Table 114. Yabao Pharmaceutical Group Business Overview Table 115. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product Portfolio Table 117. Yabao Pharmaceutical Group Recent Development Table 118. North America Nimodipine Sustained Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Nimodipine Sustained Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Nimodipine Sustained Release Tablets Sales by Type (2021-2026) & (K Units) Table 121. North America Nimodipine Sustained Release Tablets Sales by Type (2027-2032) & (K Units) Table 122. North America Nimodipine Sustained Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 123. North America Nimodipine Sustained Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 124. North America Nimodipine Sustained Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Nimodipine Sustained Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Nimodipine Sustained Release Tablets Sales by Application (2021-2026) & (K Units) Table 127. North America Nimodipine Sustained Release Tablets Sales by Application (2027-2032) & (K Units) Table 128. North America Nimodipine Sustained Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 129. North America Nimodipine Sustained Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 130. North America Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. North America Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. North America Nimodipine Sustained Release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 134. North America Nimodipine Sustained Release Tablets Sales by Country (2021-2026) & (K Units) Table 135. North America Nimodipine Sustained Release Tablets Sales by Country (2027-2032) & (K Units) Table 136. North America Nimodipine Sustained Release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 137. North America Nimodipine Sustained Release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 138. United States Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 139. Canada Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 140. Europe Nimodipine Sustained Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Nimodipine Sustained Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Nimodipine Sustained Release Tablets Sales by Type (2021-2026) & (K Units) Table 143. Europe Nimodipine Sustained Release Tablets Sales by Type (2027-2032) & (K Units) Table 144. Europe Nimodipine Sustained Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 145. Europe Nimodipine Sustained Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 146. Europe Nimodipine Sustained Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Nimodipine Sustained Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Nimodipine Sustained Release Tablets Sales by Application (2021-2026) & (K Units) Table 149. Europe Nimodipine Sustained Release Tablets Sales by Application (2027-2032) & (K Units) Table 150. Europe Nimodipine Sustained Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 151. Europe Nimodipine Sustained Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Europe Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Nimodipine Sustained Release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 156. Europe Nimodipine Sustained Release Tablets Sales by Country (2021-2026) & (K Units) Table 157. Europe Nimodipine Sustained Release Tablets Sales by Country (2027-2032) & (K Units) Table 158. Europe Nimodipine Sustained Release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 159. Europe Nimodipine Sustained Release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 160. Germany Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 161. France Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 162. U.K. Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 163. Italy Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 164. Netherlands Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 165. China Nimodipine Sustained Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 166. China Nimodipine Sustained Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 167. China Nimodipine Sustained Release Tablets Sales by Type (2021-2026) & (K Units) Table 168. China Nimodipine Sustained Release Tablets Sales by Type (2027-2032) & (K Units) Table 169. China Nimodipine Sustained Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 170. China Nimodipine Sustained Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 171. China Nimodipine Sustained Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 172. China Nimodipine Sustained Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 173. China Nimodipine Sustained Release Tablets Sales by Application (2021-2026) & (K Units) Table 174. China Nimodipine Sustained Release Tablets Sales by Application (2027-2032) & (K Units) Table 175. China Nimodipine Sustained Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 176. China Nimodipine Sustained Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Asia Nimodipine Sustained Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Nimodipine Sustained Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Nimodipine Sustained Release Tablets Sales by Type (2021-2026) & (K Units) Table 180. Asia Nimodipine Sustained Release Tablets Sales by Type (2027-2032) & (K Units) Table 181. Asia Nimodipine Sustained Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 182. Asia Nimodipine Sustained Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 183. Asia Nimodipine Sustained Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Nimodipine Sustained Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Nimodipine Sustained Release Tablets Sales by Application (2021-2026) & (K Units) Table 186. Asia Nimodipine Sustained Release Tablets Sales by Application (2027-2032) & (K Units) Table 187. Asia Nimodipine Sustained Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 188. Asia Nimodipine Sustained Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 189. Asia Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Nimodipine Sustained Release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. Asia Nimodipine Sustained Release Tablets Sales by Country (2021-2026) & (K Units) Table 194. Asia Nimodipine Sustained Release Tablets Sales by Country (2027-2032) & (K Units) Table 195. Asia Nimodipine Sustained Release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 196. Asia Nimodipine Sustained Release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 197. Japan Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 198. South Korea Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 199. India Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 200. Australia Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 201. China Taiwan Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Nimodipine Sustained Release Tablets Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Nimodipine Sustained Release Tablets Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Nimodipine Sustained Release Tablets Sales by Type (2021-2026) & (K Units) Table 206. SAMEA Nimodipine Sustained Release Tablets Sales by Type (2027-2032) & (K Units) Table 207. SAMEA Nimodipine Sustained Release Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 208. SAMEA Nimodipine Sustained Release Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 209. SAMEA Nimodipine Sustained Release Tablets Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Nimodipine Sustained Release Tablets Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Nimodipine Sustained Release Tablets Sales by Application (2021-2026) & (K Units) Table 212. SAMEA Nimodipine Sustained Release Tablets Sales by Application (2027-2032) & (K Units) Table 213. SAMEA Nimodipine Sustained Release Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 214. SAMEA Nimodipine Sustained Release Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 215. SAMEA Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Nimodipine Sustained Release Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 219. SAMEA Nimodipine Sustained Release Tablets Sales by Country (2021-2026) & (K Units) Table 220. SAMEA Nimodipine Sustained Release Tablets Sales by Country (2027-2032) & (K Units) Table 221. SAMEA Nimodipine Sustained Release Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 222. SAMEA Nimodipine Sustained Release Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 223. Brazil Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 224. Argentina Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 225. Chile Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 226. Colombia Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 227. Peru Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 229. Israel Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 230. UAE Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 231. Turkey Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 232. Iran Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 233. Egypt Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Nimodipine Sustained Release Tablets Distributors List Table 237. Nimodipine Sustained Release Tablets Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Nimodipine Sustained Release Tablets Image Figure 2. Global Nimodipine Sustained Release Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nimodipine Sustained Release Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 30mg/Piece Image Figure 5. 60mg/Piece Image Figure 6. Others Image Figure 7. Global Nimodipine Sustained Release Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nimodipine Sustained Release Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Pharmacy Image Figure 11. Others Image Figure 12. Global Nimodipine Sustained Release Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Nimodipine Sustained Release Tablets Revenue (2021-2032) & (US$ Million) Figure 14. Global Nimodipine Sustained Release Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Nimodipine Sustained Release Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Nimodipine Sustained Release Tablets Revenue Market Share by Region (2021-2032) Figure 17. Global Nimodipine Sustained Release Tablets Sales (2021-2032) & (K Units) Figure 18. Global Nimodipine Sustained Release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Nimodipine Sustained Release Tablets Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Nimodipine Sustained Release Tablets Sales YoY (2021-2032) & (K Units) Figure 21. Europe Nimodipine Sustained Release Tablets Sales YoY (2021-2032) & (K Units) Figure 22. China Nimodipine Sustained Release Tablets Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Nimodipine Sustained Release Tablets Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Nimodipine Sustained Release Tablets Sales YoY (2021-2032) & (K Units) Figure 25. Global Nimodipine Sustained Release Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Nimodipine Sustained Release Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Nimodipine Sustained Release Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2021-2032) Figure 31. Global Nimodipine Sustained Release Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Nimodipine Sustained Release Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2021-2032) Figure 34. Global Nimodipine Sustained Release Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2021-2032) Figure 37. Global Nimodipine Sustained Release Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Nimodipine Sustained Release Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2021-2032) Figure 40. North America Nimodipine Sustained Release Tablets Revenue Share by Type (2021-2032) Figure 41. North America Nimodipine Sustained Release Tablets Sales Share by Type (2021-2032) Figure 42. North America Nimodipine Sustained Release Tablets Revenue Share by Application (2021-2032) Figure 43. North America Nimodipine Sustained Release Tablets Sales Share by Application (2021-2032) Figure 44. North America Nimodipine Sustained Release Tablets Revenue Share by Country (2021-2032) Figure 45. North America Nimodipine Sustained Release Tablets Sales Share by Country (2021-2032) Figure 46. Europe Nimodipine Sustained Release Tablets Revenue Share by Type (2021-2032) Figure 47. Europe Nimodipine Sustained Release Tablets Sales Share by Type (2021-2032) Figure 48. Europe Nimodipine Sustained Release Tablets Revenue Share by Application (2021-2032) Figure 49. Europe Nimodipine Sustained Release Tablets Sales Share by Application (2021-2032) Figure 50. Europe Nimodipine Sustained Release Tablets Revenue Share by Country (2021-2032) Figure 51. Europe Nimodipine Sustained Release Tablets Sales Share by Country (2021-2032) Figure 52. China Nimodipine Sustained Release Tablets Revenue Share by Type (2021-2032) Figure 53. China Nimodipine Sustained Release Tablets Sales Share by Type (2021-2032) Figure 54. China Nimodipine Sustained Release Tablets Revenue Share by Application (2021-2032) Figure 55. China Nimodipine Sustained Release Tablets Sales Share by Application (2021-2032) Figure 56. Asia Nimodipine Sustained Release Tablets Revenue Share by Type (2021-2032) Figure 57. Asia Nimodipine Sustained Release Tablets Sales Share by Type (2021-2032) Figure 58. Asia Nimodipine Sustained Release Tablets Revenue Share by Application (2021-2032) Figure 59. Asia Nimodipine Sustained Release Tablets Sales Share by Application (2021-2032) Figure 60. Asia Nimodipine Sustained Release Tablets Revenue Share by Country (2021-2032) Figure 61. Asia Nimodipine Sustained Release Tablets Sales Share by Country (2021-2032) Figure 62. SAMEA Nimodipine Sustained Release Tablets Revenue Share by Type (2021-2032) Figure 63. SAMEA Nimodipine Sustained Release Tablets Sales Share by Type (2021-2032) Figure 64. SAMEA Nimodipine Sustained Release Tablets Revenue Share by Application (2021-2032) Figure 65. SAMEA Nimodipine Sustained Release Tablets Sales Share by Application (2021-2032) Figure 66. SAMEA Nimodipine Sustained Release Tablets Revenue Share by Country (2021-2032) Figure 67. SAMEA Nimodipine Sustained Release Tablets Sales Share by Country (2021-2032) Figure 68. Nimodipine Sustained Release Tablets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Nimodipine Sustained Release Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg/Piece
  • 60mg/Piece
  • Others
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Arbor Pharmaceuticals
  • Bayer Vital
  • Bionpharma
  • Heritage Pharmaceuticals
  • Pharmaceutics International
  • Sofgen Pharmaceuticals
  • Wuhan HITECK Biopharmaceutical
  • Sihuan Pharmaceutical
  • Jiangsu Kanion Pharmaceutical
  • Qilu Pharmaceutical
  • Shandong Yunmen Pharmaceutical
  • Yabao Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nimodipine Sustained Release Tablets Market by Type
  3. 1.2.1 Global Nimodipine Sustained Release Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 30mg/Piece
  5. 1.2.3 60mg/Piece
  6. 1.2.4 Others
  7. 1.3 Nimodipine Sustained Release Tablets Market by Application
  8. 1.3.1 Global Nimodipine Sustained Release Tablets Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Pharmacy
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Nimodipine Sustained Release Tablets Market Dynamics
  1. 2.1 Nimodipine Sustained Release Tablets Industry Trends
  2. 2.2 Nimodipine Sustained Release Tablets Industry Drivers
  3. 2.3 Nimodipine Sustained Release Tablets Industry Opportunities and Challenges
  4. 2.4 Nimodipine Sustained Release Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nimodipine Sustained Release Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nimodipine Sustained Release Tablets Revenue by Region
  3. 3.2.1 Global Nimodipine Sustained Release Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nimodipine Sustained Release Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Nimodipine Sustained Release Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Nimodipine Sustained Release Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nimodipine Sustained Release Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nimodipine Sustained Release Tablets Sales by Region
  9. 3.4.1 Global Nimodipine Sustained Release Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nimodipine Sustained Release Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Nimodipine Sustained Release Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Nimodipine Sustained Release Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nimodipine Sustained Release Tablets Revenue by Manufacturers
  2. 4.1.1 Global Nimodipine Sustained Release Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nimodipine Sustained Release Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nimodipine Sustained Release Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nimodipine Sustained Release Tablets Sales by Manufacturers
  6. 4.2.1 Global Nimodipine Sustained Release Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nimodipine Sustained Release Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nimodipine Sustained Release Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nimodipine Sustained Release Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nimodipine Sustained Release Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nimodipine Sustained Release Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nimodipine Sustained Release Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Nimodipine Sustained Release Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nimodipine Sustained Release Tablets Market CR5 and HHI
  16. 4.8.2 2025 Nimodipine Sustained Release Tablets Tier 1, Tier 2, and Tier 3
5 Nimodipine Sustained Release Tablets Market by Type
  1. 5.1 Global Nimodipine Sustained Release Tablets Revenue by Type
  2. 5.1.1 Global Nimodipine Sustained Release Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nimodipine Sustained Release Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nimodipine Sustained Release Tablets Sales by Type
  6. 5.2.1 Global Nimodipine Sustained Release Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nimodipine Sustained Release Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nimodipine Sustained Release Tablets Price by Type
6 Nimodipine Sustained Release Tablets Market by Application
  1. 6.1 Global Nimodipine Sustained Release Tablets Revenue by Application
  2. 6.1.1 Global Nimodipine Sustained Release Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nimodipine Sustained Release Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nimodipine Sustained Release Tablets Sales by Application
  6. 6.2.1 Global Nimodipine Sustained Release Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nimodipine Sustained Release Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nimodipine Sustained Release Tablets Price by Application
7 Company Profiles
  1. 7.1 Arbor Pharmaceuticals
  2. 7.1.1 Arbor Pharmaceuticals Company Information
  3. 7.1.2 Arbor Pharmaceuticals Business Overview
  4. 7.1.3 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product Portfolio
  6. 7.1.5 Arbor Pharmaceuticals Recent Developments
  7. 7.2 Bayer Vital
  8. 7.2.1 Bayer Vital Company Information
  9. 7.2.2 Bayer Vital Business Overview
  10. 7.2.3 Bayer Vital Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Vital Nimodipine Sustained Release Tablets Product Portfolio
  12. 7.2.5 Bayer Vital Recent Developments
  13. 7.3 Bionpharma
  14. 7.3.1 Bionpharma Company Information
  15. 7.3.2 Bionpharma Business Overview
  16. 7.3.3 Bionpharma Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bionpharma Nimodipine Sustained Release Tablets Product Portfolio
  18. 7.3.5 Bionpharma Recent Developments
  19. 7.4 Heritage Pharmaceuticals
  20. 7.4.1 Heritage Pharmaceuticals Company Information
  21. 7.4.2 Heritage Pharmaceuticals Business Overview
  22. 7.4.3 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product Portfolio
  24. 7.4.5 Heritage Pharmaceuticals Recent Developments
  25. 7.5 Pharmaceutics International
  26. 7.5.1 Pharmaceutics International Company Information
  27. 7.5.2 Pharmaceutics International Business Overview
  28. 7.5.3 Pharmaceutics International Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pharmaceutics International Nimodipine Sustained Release Tablets Product Portfolio
  30. 7.5.5 Pharmaceutics International Recent Developments
  31. 7.6 Sofgen Pharmaceuticals
  32. 7.6.1 Sofgen Pharmaceuticals Company Information
  33. 7.6.2 Sofgen Pharmaceuticals Business Overview
  34. 7.6.3 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product Portfolio
  36. 7.6.5 Sofgen Pharmaceuticals Recent Developments
  37. 7.7 Wuhan HITECK Biopharmaceutical
  38. 7.7.1 Wuhan HITECK Biopharmaceutical Company Information
  39. 7.7.2 Wuhan HITECK Biopharmaceutical Business Overview
  40. 7.7.3 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product Portfolio
  42. 7.7.5 Wuhan HITECK Biopharmaceutical Recent Developments
  43. 7.8 Sihuan Pharmaceutical
  44. 7.8.1 Sihuan Pharmaceutical Company Information
  45. 7.8.2 Sihuan Pharmaceutical Business Overview
  46. 7.8.3 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio
  48. 7.8.5 Sihuan Pharmaceutical Recent Developments
  49. 7.9 Jiangsu Kanion Pharmaceutical
  50. 7.9.1 Jiangsu Kanion Pharmaceutical Company Information
  51. 7.9.2 Jiangsu Kanion Pharmaceutical Business Overview
  52. 7.9.3 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio
  54. 7.9.5 Jiangsu Kanion Pharmaceutical Recent Developments
  55. 7.10 Qilu Pharmaceutical
  56. 7.10.1 Qilu Pharmaceutical Company Information
  57. 7.10.2 Qilu Pharmaceutical Business Overview
  58. 7.10.3 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio
  60. 7.10.5 Qilu Pharmaceutical Recent Developments
  61. 7.11 Shandong Yunmen Pharmaceutical
  62. 7.11.1 Shandong Yunmen Pharmaceutical Company Information
  63. 7.11.2 Shandong Yunmen Pharmaceutical Business Overview
  64. 7.11.3 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product Portfolio
  66. 7.11.5 Shandong Yunmen Pharmaceutical Recent Developments
  67. 7.12 Yabao Pharmaceutical Group
  68. 7.12.1 Yabao Pharmaceutical Group Company Information
  69. 7.12.2 Yabao Pharmaceutical Group Business Overview
  70. 7.12.3 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product Portfolio
  72. 7.12.5 Yabao Pharmaceutical Group Recent Developments
8 North America
  1. 8.1 North America Nimodipine Sustained Release Tablets Market Size by Type
  2. 8.1.1 North America Nimodipine Sustained Release Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Nimodipine Sustained Release Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Nimodipine Sustained Release Tablets Price by Type (2021-2032)
  5. 8.2 North America Nimodipine Sustained Release Tablets Market Size by Application
  6. 8.2.1 North America Nimodipine Sustained Release Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Nimodipine Sustained Release Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Nimodipine Sustained Release Tablets Price by Application (2021-2032)
  9. 8.3 North America Nimodipine Sustained Release Tablets Market Size by Country
  10. 8.3.1 North America Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nimodipine Sustained Release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nimodipine Sustained Release Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Nimodipine Sustained Release Tablets Market Size by Type
  2. 9.1.1 Europe Nimodipine Sustained Release Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nimodipine Sustained Release Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Nimodipine Sustained Release Tablets Price by Type (2021-2032)
  5. 9.2 Europe Nimodipine Sustained Release Tablets Market Size by Application
  6. 9.2.1 Europe Nimodipine Sustained Release Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nimodipine Sustained Release Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Nimodipine Sustained Release Tablets Price by Application (2021-2032)
  9. 9.3 Europe Nimodipine Sustained Release Tablets Market Size by Country
  10. 9.3.1 Europe Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nimodipine Sustained Release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nimodipine Sustained Release Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Nimodipine Sustained Release Tablets Market Size by Type
  2. 10.1.1 China Nimodipine Sustained Release Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Nimodipine Sustained Release Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Nimodipine Sustained Release Tablets Price by Type (2021-2032)
  5. 10.2 China Nimodipine Sustained Release Tablets Market Size by Application
  6. 10.2.1 China Nimodipine Sustained Release Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Nimodipine Sustained Release Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Nimodipine Sustained Release Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nimodipine Sustained Release Tablets Market Size by Type
  2. 11.1.1 Asia Nimodipine Sustained Release Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nimodipine Sustained Release Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Nimodipine Sustained Release Tablets Price by Type (2021-2032)
  5. 11.2 Asia Nimodipine Sustained Release Tablets Market Size by Application
  6. 11.2.1 Asia Nimodipine Sustained Release Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nimodipine Sustained Release Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Nimodipine Sustained Release Tablets Price by Application (2021-2032)
  9. 11.3 Asia Nimodipine Sustained Release Tablets Market Size by Country
  10. 11.3.1 Asia Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nimodipine Sustained Release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nimodipine Sustained Release Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nimodipine Sustained Release Tablets Market Size by Type
  2. 12.1.1 SAMEA Nimodipine Sustained Release Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nimodipine Sustained Release Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nimodipine Sustained Release Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Nimodipine Sustained Release Tablets Market Size by Application
  6. 12.2.1 SAMEA Nimodipine Sustained Release Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nimodipine Sustained Release Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nimodipine Sustained Release Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Nimodipine Sustained Release Tablets Market Size by Country
  10. 12.3.1 SAMEA Nimodipine Sustained Release Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nimodipine Sustained Release Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nimodipine Sustained Release Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nimodipine Sustained Release Tablets Value Chain Analysis
  2. 13.1.1 Nimodipine Sustained Release Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nimodipine Sustained Release Tablets Production Mode & Process
  6. 13.2 Nimodipine Sustained Release Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nimodipine Sustained Release Tablets Distributors
  9. 13.2.3 Nimodipine Sustained Release Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst